"L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial".

Arpan JainBarjesh Chander SharmaBhawna MahajanSiddharth SrivastavaAjay KumarSanjeev SachdevaUjjwal SonikaAshok Dalal

Published in: Hepatology (Baltimore, Md.) (2021)

Combination of LOLA with lactulose and rifaximin was more effective than only lactulose and rifaximin in improving grades of HE, recovery time from encephalopathy with lower 28-day mortality.

Keyphrases

early onset
randomized controlled trial
liver failure
study protocol
drug induced
irritable bowel syndrome
risk factors
type diabetes
systematic review
intensive care unit
combination therapy
extracorporeal membrane oxygenation